Satisfaction of Hospitalized Diabetic Patients Using a Continuous Glucose Monitoring System
NCT ID: NCT03411460
Last Updated: 2018-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
10 participants
INTERVENTIONAL
2017-04-19
2017-08-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can Continuous Glucose Measurements Help Diabetic Patients Treated With an Implantated Pump?
NCT03048227
Comparison of Real-tiMe ContInuous gLucosE moNitoriNg With Self-monitorIng of Blood Glucose in Young AduLts With Type 1 diabeteS
NCT03445377
Continuous Glucose Monitoring Initiation at Hospital Discharge
NCT04854135
Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous Glucose Data
NCT03028220
Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin Pump
NCT03653533
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interstitial glucose
Glucose level tested by continuous monitoring device
FreeStyle Libre™ system
Measured non-invasively via scanner
Blood glucose
Glucose level tested on glucose monitor using standard finger prick
Finger prick
Blood test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FreeStyle Libre™ system
Measured non-invasively via scanner
Finger prick
Blood test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be insured or the beneficiary of an insurance policy
* The patient is aged at least 18 years and less than 75 years old.
* Patients have a BMI between 18 and 40kg/m2
* Diabetic patient admitted for glycemic instability with indication for treatment using an external insulin pump but otherwise in a stable clinical state
Exclusion Criteria
* The subject is in an exclusion period determined by a previous study
* The patients is under judicial protection or state guardianship
* The subject refuses to sign the consent form
* It proves impossible to give the subject clear information.
* The patient is pregnant, parturient or breastfeeding
* The patient is clinically unstable
* BMI less than 18 or over 40
* Existence of a severe rapidly progressive ischemic retinopathy or proliferative retinopathy.
* Serious psychiatric problems
* Chronic cutaneous infection
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Nimes
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LOCAL/2016/MR-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.